Cogent Biosciences Inc to Host ASH Investor Event Transcript
Yes, good morning, and welcome to Cogent Biosciences webcast. I will now turn the call over to Christi Waarich, Senior Director of Investor Relations.
Thank you, operator. For today's call, we'll review the summer and APEX data value embedded cancer in patients with non there in advanced systemic mastocytosis. These data were presented and released in the press release over the weekend and earlier this morning, you can find the press release in the Investors and Media section of our website at cogentco.com.
Before we get started, please be reminded that remarks made during this call may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans, clinical development time lines, including future presentations of clinical data financial projection.
While these forward-looking statements represent our views as of today, they should not be relied upon as representing our views in the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
